You are here

crinecerfont

Neurocrine’s hopes for hyperplasia blockbuster a step closer after phase 3 win

Fierce Biotech

Tue, 09/12/23 - 10:47 am

Neurocrine Biosciences

clinical trials

congenital adrenal hyperplasia